AbbVie (ABBV)
NYSE:ABBV
Holding ABBV?
Track your performance easily

AbbVie (ABBV) Ownership - Who Owns AbbVie?

21,417 Followers

AbbVie (ABBV) Ownership Overview

0.08%22.02%5.11%20.98%51.81%
5.11% Other Institutional Investors
20.98% ETFs
51.81% Public Companies and Individual Investors
The ownership structure of AbbVie (ABBV) stock is a mix of institutional, retail, and individual investors. Approximately 48.11% of the company’s stock is owned by Institutional Investors, 0.08% is owned by Insiders, and 51.81% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 07, 2024
Richard A. Gonzalez
Executive Chairman Of Board,director
xxxxxxxxxxxxx
$12403580
Jul 19, 2024
Richard A. Gonzalez
Executive Chairman Of Board,director
xxxxxxxxxxxxx
$49497875
Mar 22, 2024
Nicholas Donoghoe
Evp, Chief Bus/strat Officer
xxxxxxxxxxxxx
$3716757
Mar 20, 2024
xxxxxxxxxxxxx
$10539508

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
152,025,855Institution8.60%30,329,158,073
117,594,540Institution6.65%23,460,110,730
70,296,773Institution3.98%14,024,206,214
67,638,619Institution3.83%13,493,904,491
28,643,717Institution1.62%5,714,421,542
18,814,926Institution1.06%3,753,577,737
16,901,130Institution0.96%3,371,775,435
15,747,432Institution0.89%3,141,612,684
13,628,349Institution0.77%2,718,855,626
12,561,914Institution0.71%2,506,101,843

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
117,594,540Institution6.65%23,460,110,730
28,643,717Institution1.62%5,714,421,542
18,814,926Institution1.06%3,753,577,737
15,747,432Institution0.89%3,141,612,684
13,628,349Institution0.77%2,718,855,626
12,561,914Institution0.71%2,506,101,843
9,537,710Institution0.54%1,902,773,145
8,058,193Institution0.46%1,607,609,504
7,903,143Institution0.45%1,576,677,029
7,639,367Institution0.43%1,524,053,717

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
55,945,853Institution3.17%11,048,187,050
46,266,602Institution2.62%9,136,728,563
21,803,983Institution1.23%4,371,916,631
21,803,983Institution1.23%4,371,916,631
19,690,086Institution1.11%3,928,172,157
14,941,569Institution0.85%2,950,661,046
12,949,631Institution0.73%2,596,530,512
12,697,081Institution0.72%2,545,891,711
9,532,437Institution0.54%1,882,465,659
7,271,266Institution0.41%1,435,929,610

FAQ

Who Owns AbbVie (ABBV)?
According to the latest TipRanks data, approximately 5.11% of the company's stock is held by institutional investors, 0.08% is held by insiders, and 51.81% is held by retail investors.
    What percentage of AbbVie (ABBV) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 5.11% of AbbVie (ABBV) stock is held by institutional investors.
      What percentage of AbbVie (ABBV) stock is held by retail investors?
      According to the latest TipRanks data, approximately 51.81% of AbbVie (ABBV) stock is held by retail investors.
        Who owns the most shares of AbbVie (ABBV)?
        Vanguard owns the most shares of AbbVie (ABBV).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis